|
Volumn 5, Issue 5, 2012, Pages 701-705
|
Does vitamin E prevent or promote cancer?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA TOCOPHEROL;
ALPHA TOCOTRIENOL;
ASCORBIC ACID;
BETA CAROTENE;
BETA TOCOPHEROL;
DELTA TOCOPHEROL;
GAMMA TOCOPHEROL;
GAMMA TOCOTRIENOL;
SELENIUM;
SELENOMETHIONINE;
ANTINEOPLASTIC AGENT;
TOCOPHEROL;
ANTINEOPLASTIC ACTIVITY;
ANTIOXIDANT ACTIVITY;
CANCER PREVENTION;
CANCER RISK;
COLON CANCER;
DRUG CARCINOGENICITY;
DRUG MECHANISM;
DRUG STRUCTURE;
FATTY ACID OMEGA OXIDATION;
FATTY ACID OXIDATION;
HUMAN;
LUNG CANCER;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
RISK REDUCTION;
VITAMIN BLOOD LEVEL;
VITAMIN SUPPLEMENTATION;
ANIMAL;
BIOLOGICAL MODEL;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL (TOPIC);
DISEASE MODEL;
EVALUATION;
METHODOLOGY;
NEOPLASM;
PHYSIOLOGY;
REVIEW;
VITAMIN DEFICIENCY;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AVITAMINOSIS;
CHEMOPREVENTION;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
HUMANS;
MODELS, BIOLOGICAL;
NEOPLASMS;
TOCOPHEROLS;
VITAMIN E;
|
EID: 84866179913
PISSN: 19406207
EISSN: 19406215
Source Type: Journal
DOI: 10.1158/1940-6207.CAPR-12-0045 Document Type: Note |
Times cited : (93)
|
References (6)
|